At least seven disorders are part of or closely related to Autism. Each disorder has symptoms commonly seen with autism, as well as its own specific symptoms. Choose from the index below to jump to the desired information.
ARI thanks Stephen M. Edelson, PhD, for his contribution to this content.
Williams Syndrome (also known as Williams-Beuren syndrome) is a rare genetics disorder in which a portion of DNA material on chromosome 7 is missing. The prevalence in the population is somewhere between 1 out of 10,000.
Many people with Williams Syndrome exhibit autistic behaviors. This includes: developmental and language delays, problems in gross motor skills, hypersensitivity to sounds, picky eating, and perseverating.
These individuals differ from the typical autistic individual because they also have cardiovascular abnormalities, high blood pressure, elevated calcium levels, and are very sociable. They also have unique pixie-like facial features–almond shaped eyes, oval ears, full lips, small chins, narrow faces, and broad mouths.
For more detailed information regarding this disorder please visit the Williams Syndrome Association.
Fragile X syndrome (also known as Martin-Bell syndrome) is a sex-linked genetic disorder. The exact frequency of Fragile X syndrome is unclear, but the CDC estimates that roughly 1.4 in 10,000 males and 0.9 in 10,000 females are affected by this disorder. Males afflicted with this syndrome typically have a moderate to severe form of intellectual handicap. Females may also be affected but generally have a mild form of impairment.
Approximately 15% to 20% of those with Fragile X Syndrome exhibit autistic-type behaviors, such as poor eye contact, hand-flapping or odd gesture movements, hand-biting, and poor sensory skills. Behavior problems and speech/language delay are also common features of Fragile X Syndrome.
People with Fragile X syndrome also have a number of recognizable physical features, including a high arched palate, strabismus (lazy eye), large ears, long face, large testicles in males, poor muscle tone, flat feet, and sometimes mild, heart valve abnormalities. Although most individuals with Fragile X syndrome have a characteristic ‘look’ (long face and large ears), there are some who do not have typical features.
Many hospitals and laboratories perform blood tests to diagnose Fragile X syndrome. Several treatments are recommended for individuals with this disorder, including mild medications for behavior problems and therapies for speech and language and sensory improvement. Families are advised to seek genetic counseling to understand the inheritable nature of Fragile X Syndrome and to discuss with family members the likelihood other individuals or future offspring may have this disorder.
For more information visit the National Fragile X Foundation
We would like to thank Dr. Peter Jacky of Kaiser Sunnyside Hospital in Clackamas, Oregon for his comments on this article.
Landau-Kleffner Syndrome is a rare form of epilepsy that manefests as a form of aphasia, (loss of language), which usually develops between 3 and 7 years. It is twice as common in males than females. Initially, these individuals have a healthy, problem-free development with normal speech and vocabulary. These individuals first lose their ability to comprehend (i.e., receptive speech) and then their ability to speak (i.e., expressive speech). These changes can occur gradually or suddenly.
People with Landau-Kleffner Syndrome have abnormal EEG patterns (i.e., brain waves) in the temporal lobe (located on the sides of the brain) and in the temporo-parieto-occipital regions during sleep. Diagnosis of this syndrome usually involves examining the person’s EEG patterns during sleep. Approximately 70% develop epilepsy; and these seizures are typically infrequent and can be either with or without convulsions.
One common characteristic of Landau-Kleffner Syndrome, which is often diagnosed in conjunction with autism, is the failure to respond to sounds. Thus, parents may suspect their child of hearing loss. Autistic characteristics seen in Landau-Kleffner Syndrome individuals include pain insensitivity, aggression, poor eye contact, insistence on sameness, and sleep problems.
The cause of Landau-Kleffner Syndrome is not known. Some suggested causes have been a dysfunctional immune system, exposure to a virus, and brain trauma. The prognosis is better when the onset is after age 6 and when speech therapy is started early. Several other treatments have also been shown to be beneficial for many of these individuals, such as anticonvulsant mediations and corticosteroids. There is also a surgical technique in which the pathways of abnormal electrical brain activity are severed.
For additional information, visit the Epilepsy Foundation
Prader-Willi Syndrome is a disorder which is sometimes associated with, but not a subtype of, autism. The classical features of this disorder include an obsession with food which is often associated with impulsive eating, compact body build, underdeveloped sexual characteristics, and poor muscle tone. Because of their obsession with food, many people afflicted with Prader-Willi Syndrome are overweight. Most individuals afflicted with Prader-Willi Syndrome have mild mental defecits.
Some of the behaviors which are common to both Prader-Willi Syndrome and autism are:
- delays in language and motor development
- learning disabilities
- feeding problems in infancy
- sleep disturbances, skin picking
- temper tantrums
- high pain threshold
Prader-Willi Syndrome affects approximately 1 in 10,000 people. Most individuals suffering from this disorder are missing a small portion of chromosome 15 which appears to come from the paternal side of the family. When a small portion of chromosome 15 is missing and comes from the maternal side, the person may suffer from Angelman Syndrome.
The most effective form of treatment for people suffering from Prader-Willi Syndrome is behavior modification. In general, medications do not appear to very effective for these individuals.
Angelman syndrome is a genetic disorder that affects the nevrous system. Initial symptoms of this disorder typically manifests in the first year of life and become more apparent through early childhood. It is estimated that Angelman syndrome occurs in roughly every one in 15,000 people. Similarly to Prader Willi Syndrome, this disorder derives from a missing portion of chromosme 15, but unlike Prader Willi this deficit comes from the maternal side.
Angelman syndrome is commonly characterized by:
- Mental and speech defecits
- Speach impairment
- Problems with motor skills and balance
- Small head size
- Smiling, Laughing and Hand flapping
- Difficulty sleeping
To learn more about Angelman Syndrome, please visit the Angelman Syndrome Foundation
Rett Syndrome was first recognized by Andreas Rett in 1966 and is a neurological disorder affecting primarily females. Autopsies on the brains of these individuals indicate a pathology different than autism; however, children afflicted with Rett Syndrome often exhibit autistic-like behaviors, such as repetitive hand movements, prolonged toe walking, body rocking, and sleep problems. In most cases, there is a regression in cognition, behavior, social, and motor skills throughout their lifetime.
The prevalence of Rett Syndrome is estimated to be between 1 in 10,000 and 1 in 15,000 people.
- Normal development until 1/2 to 1 1/2 years
- Behavioral, social, and cognative regression
- Shakiness of the torso, and possibly the limbs
- Unsteady, stiff-legged gait
- Breathing difficulties (hyperventilation, apnea, air swallowing)
- Seizures (approximately 80% have epilepsy)
- Teeth grinding and difficulty chewing
- Stunted growth and small head
- Severe mental defecits
In 1999, Dr. Huda Zoghbi and her colleagues located the gene for Rett syndrome. The gene was located on one of the two X chromosomes that determine sex. Rett syndrome results from the mutation of the gene that makes methyl cytosine binding proetin, resulting in excessive amounts of this protein.
For more information about this disorder, visit International Rett Syndrome Association
Tardive dyskinesia is a syndrome involving dysfunctional, involuntary movements associated with long-term, chronic use of neuroleptic medications, such as Haldol, Prolixin, and Thorazine. These drugs lead to an apparent general calming or sedative effect on the individual and are considered major tranquilizers.
Tardive dyskinesia may appear anywhere from three months to several years after initial use of these medications, and withdrawal from neuroleptics often exacerbates the symptoms.
Common tardive dyskinesia movements include, but are not limited to:
- facial tics, grimacing
- eye blinking
- lip smacking
- tongue thrusting
- moving one’s head back or to the side
- foot tapping
- ankle movements
- shuffled gait
- head nodding
Tardive dyskinesia may lead to very serious problems, such as respiratory interference, inability to eat, oral ulcerations, and difficulty standing/walking.
Tardive dyskinesia movements may be confused with stereotypy because of the repetitive nature of both behaviors. Stereotypy refers to ritualistic, often complex behaviors, such as body and head rocking, hand-flapping, and complex hand movement patterns. Stereotypy appears to be under voluntary control. In contrast, tardive dyskinesia movements are less complex, less ritualistic, and are not volitional.
Other psychoactive drugs, such as clozaril/clozapine, have similar effects on behavior but do not produce tardive dyskinesia as neuroleptics do. If neuroleptic drugs have been used, or are being used, there is substantial evidence (at least seven studies) which show that tardive dyskinesia can be avoided and/or treated, through the use of certain nutrients, especially vitamin E. One professional suggests the following to prevent or treat tardive dyskinesia:
- Vitamin E, 400-800 units/day
- Vitamin B6, 100-200 mg./day
- Vitamin C, 1000 mg./day
- Vitamin B3, 100-200 mg./day (niacinamide)
- Multiple mineral tablet containing about 3-5 mg. of manganese
Due to the serious side effects of neuroleptics and given that not everyone responds positively to the drugs, it is best to address behavioral problems with behavior management strategies. The majority of behavioral problems are environmentally caused. Treatment of behavioral problems with neuroleptics may cause additional social and physiological problems; therefore, they should be carefully considered before being utilized.
Special thanks to Julie Genz for her comments on an earlier draft.
Learn about emerging research on the effectiveness of cannabidivarin (CBDV) on irritability and repetitive behaviors in children with ASD. CBDV is a non-psychoactive chemical compound and does not cause
Vicki Kobliner MS RDN is a Registered Dietitian/Nutritionist with years of expertise in applying a functional approach to nutrition. She develops individualized plans for clients